March 24, 2020
Chugai Pharmaceutical, together with Roche and Genentech, have filed a patent infringement lawsuit in the US against Fresenius Kabi USA and affiliates for their generic version of the ALK inhibitor Alecensa (alectinib), the Japanese company said on March 23. The...read more